Key figures

Second quarter, April 1 – June 30, 2026

(Figures in parentheses refer to the corresponding period in the previous year.)

  • Net sales amounted to 0 (0).
  • Other operating income amounted to 2,840 (13,945) thousand SEK.
  • Operating profit (EBIT) amounted to -8,304 (-15,346) thousand SEK.
  • Profit after tax amounted to -8,304 (-12,740) thousand SEK.
  • Earnings per share before and after dilution: -0.69 (-1.81) SEK.
  • Cash flow from operating activities was 7,766 (-4,699) thousand SEK.

 

First half of the year, January 1 – June 30, 2026

(Figures in parentheses refer to the corresponding period in the previous year.)

  • Net sales amounted to 0 (0).
  • Other operating income amounted to 4,042 (15,607) thousand SEK.
  • Operating profit (EBIT) amounted to -18,694 (-26,281) thousand SEK.
  • Profit after tax amounted to -18,694 (-26,281) thousand SEK.
  • Earnings per share before and after dilution: -1.55 (-3.38) SEK.
  • Cash flow from operating activities was -4,874 (-13,875) thousand SEK.

 

Significant events during the quarter

  • Selected as semi-finalist in the ADLM 2026 Disruptive Technology Award Competition.
  • Positive patent decision in Japan.
  • Design freeze achieved for the Psyros instrument.
  • Positive patent decision in the United States.

 

Significant events after the end of the period

  • A feasibility study, on traumatic brain injury (TBI), involving 260 patient samples demonstrated excellent results and formed the basis for the signing of a SEK 29 million development agreement with BRAINBox Solutions.